The semaglutide shortage probably won’t last forever. But for now, physicians strive to provide the best care for their patients as they navigate the shortage as part of a crucial aspect of their practice. But even when drug manufacturers like Novo Nordisk straighten out supply chain issues and the obesity drug Wegovy, for instance, becomes...